Country deals of the year: China
There has been a tidal wave of Chinese IPOs, but one stood out above the others. Sinopharm Group's US$1.3 billion debut in Hong Kong attracted huge interest and wins Asiamoney's award as China's best of the past year.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: